Semax: what it is and what the evidence says
A peptide studied for its relationship with neuroprotection and modulation of factors linked to cognitive function and focus.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
The brain adapts by forming and strengthening connections. Neurotransmitters take part in that conversation, along with factors that help neurons survive and grow. Compounds in this group are studied for their relationship with focus, memory, mood or neuroprotection — and it is worth saying plainly that this is the area where claims are most exaggerated and where human evidence is thinnest.
What it is studied for
Focus, memory, mental clarity.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
Human evidence is limited to small Russian trials in ischemic stroke and to neuroimaging studies in healthy volunteers. There is no independently replicated randomized trial outside Russia.
The limitation that matters most
It is approved and marketed only in Russia and some CIS countries, with no FDA or EMA approval, and nearly its entire experimental base consists of rat studies published by the same groups that developed the drug.
Regulatory status
Registered only in Russia and the CIS.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
Variable individual response; evidence largely outside large trials.
With neurological or psychiatric conditions, consult a professional before considering it.
What this page cannot give you
A reference page can take you this far. You know what Semax is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]human Zh Nevrol Psikhiatr Im S S Korsakova · 2018 · PMID 29798983 →
- Effects of Semax on the Default Mode Network of the Brainhuman Bull Exp Biol Med · 2018 · PMID 30225715 →
- The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysispreclinical BMC Genomics · 2014 · PMID 24661604 →
- Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrainpreclinical J Neurochem · 2006 · PMID 16635254 →
- Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusionpreclinical Int J Mol Sci · 2021 · PMID 34201112 →
- Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Ratspreclinical Genes (Basel) · 2020 · PMID 32580520 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for Semax or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is Semax?
A peptide studied for its relationship with neuroprotection and modulation of factors linked to cognitive function and focus. It is studied within the area of cognitive.
Is there human evidence for Semax?
Human evidence is limited to small Russian trials in ischemic stroke and to neuroimaging studies in healthy volunteers. There is no independently replicated randomized trial outside Russia.
Is it approved by any health agency?
Registered only in Russia and the CIS.
What is the dose of Semax?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what Semax is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.